Search Results 681-690 of 17053 for Maize

  1. An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum - Mayo Clinic

    The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG). Participation eligibility. Participant ...

  2. Effects of Symptom Severity, Depressive and Anxiety Symptoms, and Health Behaviors on Daily Functioning and Diagnosis of Pediatric Patients with POTS or Other Autonomic Dysfunction - Mayo Clinic

    The purpose of this study is to gather information about symptoms of autonomic dysfunction, depressive and anxiety symptoms, health behaviors, social support, ...

  3. A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study to Evaluate the Long-Term Effectiveness, Safety, and Tolerability of Repeated Administration of ABT-494 in Patients with Crohn's Disease - Mayo Clinic

    The purpose of this study is to evaluate the long-term effectiveness, safety, and tolerability of giving repeat doses of ABT-494 to treat patients who have ...

  5. Magnetic Resonance Imaging, Cytometry, and Elastography Assessment of Liver Histopathology in Nonalcoholic Fatty Liver Disease - Mayo Clinic

    Magnetic Resonance Imaging, Cytometry, and Elastography Assessment of Liver Histopathology in Nonalcoholic Fatty Liver Disease · Overview · Participation ...

  6. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC - Mayo Clinic

    About this study. The purpose of ARTEMIDE-Lung03 is to evaluate the efficacy and safety of rilvegostomig compared to pembrolizumab, both in combination with ...

  7. A Study to Evaluate Belinostat and Guadecitabine or ASTX727 to Treat Unresectable and Metastatic Conventional Chondrosarcoma - Mayo Clinic

    Belinostat may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as guadecitabine, work in ...

  8. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

    The primary hypothesis of this study is that overall survival (OS) and/or progression-free survival (PFS) is prolonged in participants who receive pembrolizumab ...

  9. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

    A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of ...

  10. Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL) - Mayo Clinic

    The primary objective of this study is to determine the Maximum Tolerated Dose (MTD) for belinostat when combined with CHOP regimen and establish the ...